1 Андреева Н.С., Реброва О.Ю., Зорин Н.А. Системы оценки достоверности научных доказательств и убедительности рекомендаций: сравнительная характеристика и перспективы унификации. Медицинские технологии Оценка и выбор 2012; 4: 10 - 24.

2 Rahimtoola S.H. Foreword. Curr Probl Cardiol 2009 Mar; 34: 89.

3 Земцовский Э.В., Малев Э.Г., Березовская Г.А., Парфенова Н.Н., Реева С.В., Лунева Е.Б., et al. Наследственные нарушения соединительной ткани в кардиологии. Диагностика и лечение Российские рекомендации (I пересмотр). Российский кардиологический журнал 2013; 1: 1 - 32.

4 Carpentier A. Congenital malformations of the mitral valve Surgery for congenital heart defects. W. B. Saunders Philadelphia, 1994, 1994.

5 Бокерия Л.А., Ким А.Н., Абдувохидов Б.У., Серов Р.А., Лашнева А.С. Хирургическая анатомия митрального клапана у детей раннего возраста. Детские болезни сердца и сосудов 2012 [cited 2018 May 30]; 37 - 44.

6 Белоконь Н.А., Подзолков В.П. Врожденные пороки сердца. Медицина Москва, 1991, 1990, [cited 2021 May 28]. Available from: http://padabum.com/d.php?id=40831

7 Rothenburger M., Rukosujew A., Haimnel D., Dorenkamp A., Schmidt C., Schmid C., et al. Mitral valve surgery in patients with poor left ventricular function. Thorac Cardiovasc Surg 2002 Dec; 50: 351 - 354.

8 Bonow R.O., Carabello B., De Leon J., Edmunds J., Fedderly B.J., Freed M.D., et al. Guidelines for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease). Circulation 1998 Nov 3; 98: 1949 - 1984.

9 Freed L.A., Benjamin E.J., Levy D., Larson M.G., Evans J.C., Fuller D.L., et al. Mitral valve prolapse in the general population: The benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol 2002 Oct 2; 40: 1298 - 1304.

10 Земцовский Э.В., Малев Э.Г., Реева С.В. Пролапс митрального клапана: "много шума из ничего" или реальная и нерешенная проблема? Кардиоваскулярная терапия и профилактика 2010 [cited 2021 Sep 7]; 9: 69 - 74.

11 Park S.M., Park S.W., Casaclang-Verzosa G., Ommen S.R., Pellikka P.A., Miller F.A., et al. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: Data from the Acorn trial. Am Heart J 2009; 157: 762.e3 - 762.el0.

12 Pederzolli N., Agostini F., Fiorani V., Tappainer E., Nocchi A., Manfredi J., et al. Postendocarditis mitral valve aneurysm. J Cardiovasc Med 2009 Mar; 10: 259 - 260.

13 Carpentier A., Adams D.H., Filsoufi F. Carpentier's Reconstructive Valve Surgery - 1st Edition. Missouri: Saunders 2010; 5 - 167.

14 Nishimura R.A., Otto C.M., Bonow R.O., Carabello B.A., Erwin J.P., Fleisher L.A., et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017 Jul ll; 70: 252 - 289.

15 DaCruz E.M., Ivy D., Jaggers J. Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. London, Springer London, 2014. DOI: 10.1007/978-1-4471-4619-3

16 Boudoulas H., Kolibash A.J., Baker P., King B.D., Wooley C.F. Mitral valve prolapse and the mitral valve prolapse syndrome: A diagnostic classification and pathogenesis of symptoms. Am Heart J 1989; 118: 796 - 818.

17 Чазова Н.Е., Мартынюк Т.В., Валиева З.С., Азизов В.А., Барбараш О.Л., Веселова Т.Н., et al. Евразийские клинические рекомендации по диагностике и лечению легочной гипертензии. Евразийский кардиологический журнал 2020 Mar 30; 0: 78 - 122.

18 Mueller C., Huber P., Laifer G., Mueller B., Perruchoud A.P. Procalcitonin and the Early Diagnosis of Infective Endocarditis. Circulation 2004 Apr 13; 109: 1707 - 1710.

19 Knudsen J.B., Fuursted K., Petersen E., Wierup P., Molgaard H., Poulsen S.H., et al. Procalcitonin in 759 patients clinically suspected of infective endocarditis. Am J Med 2010 Dec; 123: 1121 - 1127.

20 Kocazeybek B., Kucukoglu S., Oner Y.A. Procalcitonin and C-reactive protein in infective endocarditis: Correlation with etiology and prognosis. Chemotherapy 2003; 49: 76 - 84.

21 Habib G., Lancellotti P., Antunes M., Bongiomi M., Casalta J., Del Zotti F., et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015 Nov 21; 36: 3075 - 3123.

22 Naderi H., Abbara A., Viviano A., Asaria P., Pabari P., Flora R., et al. Re-emphasising the importance of histopathological diagnosis in suspected bacterial endocarditis. Perfusion 2021 Aug 11; 026765912110388.

23 Gupta S., Sakhuja A., McGrath E., Asmar B. Trends, microbiology, and outcomes of infective endocarditis in children during 2000 - 2010 in the United States. Congenit Heart Dis 2017 Mar 1; 12: 196 - 201.

24 Mahony M., Lean D., Pham L., Horvath R., Suna J., Ward C., et al. Infective Endocarditis in Children in Queensland, Australia: Epidemiology, Clinical Features and Outcome. Pediatr Infect Dis J 2021 Jul 1; 40: 617 - 622.

25 Luca A., Curpan A., Adumitrachioaiei H., Ciobanu I., Dragomirescu C., Manea R., et al. Difficulties in Diagnosis and Therapy of Infective Endocarditis in Children and Adolescents-Cohort Study. Healthc (Basel, Switzerland) 2021 Jun 1; 9. DOI: 10.3390/HEALTHCARE9060760

26 Терещенко С.Н., Жиров И.В., Ускач Т.М., Саидова М.А., Голицын С.П., Гупало Е.М., et al. Клинические рекомендации Евразийской ассоциации кардиологов (ЕАК)/национального общества по изучению сердечной недостаточности и заболеваний миокарда (НОИСН) по диагностике и лечению хронической сердечной недостаточности (2020). Евразийский кардиологический журнал 2020 Sep 30; 6 - 76.

27 Baumgartner H., Falk V., Bax J.J., De Bonis M., Hamm C., Holm P.J., et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017 Sep 21; 38: 2739 - 2786.

28 Nishimura R.A., O'Gara P.T., Bavaria J.E., Brindis R.G., Carroll J.D., Kavinsky C.J., et al. 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2019 May 28; 73: 2609 - 2635.

29 Falk V., Baumgartner H., Bax J.J., De Bonis M., Hamm C., Holm P.J., et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2017 Oct 1; 52: 616 - 664.

30 Gripari P., Muratori M., Fusini L., Tamborini G., Pepi M. Three-dimensional echocardiography: Advancements in qualitative and quantitative analyses of mitral valve morphology in mitral valve prolapse. J Cardiovasc Echogr 2014; 24: 1 - 9.

31 Sachdeva R., Valente A., Armstrong A., Cook S., Han B., Lopez L., et al. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease: A Report of the American College of Cardiology Solution Set Oversight Committee and Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society. J Am Soc Echocardiogr 2020 Oct l; 33: e1 - e48.

32 Takahashi K., Mackie A.S., Rebeyka I.M., Ross D.B., Robertson M., Dyck J.D., et al. Two-Dimensional Versus Transthoracic Real-Time Three-Dimensional Echocardiography in the Evaluation of the Mechanisms and Sites of Atrioventricular Valve Regurgitation in a Congenital Heart Disease Population. J Am Soc Echocardiogr 2010 Jul; 23: 726 - 734.

33 Cantinotti M., Giordano R., Koestenberger M., Voges I., Santoro G., Franchi E., et al. Echocardiographic examination of mitral valve abnormalities in the paediatric population: current practices. Cardiol Young 2020; 30: 1 - 11.

34 Takahashi K., Mackie A., Rebeyka I., Ross D., Robertson M., Dyck J., et al. Two-dimensional versus transthoracic real-time three-dimensional echocardiography in the evaluation of the mechanisms and sites of atrioventricular valve regurgitation in a congenital heart disease population. J Am Soc Echocardiogr 2010 Jul; 23: 726 - 734.

35 Castello R., Fagan L., Lenzen P., Pearson A.C., Labovitz A.J. Comparison of transthoracic and transesophageal echocardiography for assessment of left-sided valvular regurgitation. Am J Cardiol 1991 Dec 15; 68: 1677 - 1680.

36 Бокерия Л.А., Голухова Е.З., Машина Т.В. Трехмерная эхокардиография. НЦ ССХ им. 2002.

37 Adams D.H., Rosenhek R., Falk V. Degenerative mitral valve regurgitation: Best practice revolution. Eur Heart J 2010 Aug; 31. DOI: 10.1093/eurheartj/ehq222

38 Agricola E., Oppizzi M., Pisani M., Maisano F., Margonato A. Accuracy of real-time 3D echocardiography in the evaluation of functional anatomy of mitral regurgitation. Int J Cardiol 2008 Jul 21; 127: 342 - 349.

39 La Canna G., Arendar I., Maisano F., Monaco F., Collu E., Benussi S., et al. Real-time three-dimensional transesophageal echocardiography for assessment of mitral valve functional anatomy in patients with prolapse-related regurgitation. Am J Cardiol 2011 May 1; 107: 1365 - 1374.

40 Sagie A., Freitas N., Chen M.H., Marshall J.E., Weyman A.K., Levine R.A. Echocardiographic assessment of mitral stenosis and its associated valvular lesions in 205 patients and lack of association with mitral valve prolapse. J Am Soc Echocardiogr 1997; 10: 141 - 148.

41 Cantinotti M., Giordano R., Emdin M., Assanta N., Crocetti M., Marotta M., et al. Echocardiographic assessment of pediatric semilunar valve disease. Echocardiography 2017 Sep 1; 34: 1360 - 1370.

42 Ben Zekry S., Nagueh S.F., Little S.H., Quinones M.A., McCulloch M.L., Karanbir S., et al. Comparative accuracy of two- and three-dimensional transthoracic and transesophageal echocardiography in identifying mitral valve pathology in patients undergoing mitral valve repair: Initial observations. J Am Soc Echocardiogr 2011 Oct; 24: 1079 - 1085.

43 Sheman S.K. Perioperative transesophageal echocardiographic evaluation of the native mitral valve. Crit Care Med 2007 Aug; 35. DOI: 10.1097/01.CCM.0000270248.34274.AB

44 Carabello B.A., Nolan S.P., McGuire L.B. Assessment of preoperative left ventricular function in patients with mitral regurgitation: Value of the end-systolic wall stress-end-systolic volume ratio. Circulation 1981; 64: 1212 - 1217.

45 Enriquez-Sarano M., Schaff H.V., Orszulak T.A., Tajik A.J., Bailey K.R., Frye R.L. Valve repair improves the outcome of surgery for mitral regurgitation: A multivariate analysis. Circulation 1995 Feb 15; 91: 1022 - 1028.

46 Enriquez-Sarano M., Tribouilloy C. Quantitation of mitral regurgitation: Rationale, approach, and interpretation in clinical practice. Heart 2002; 88. DOI: 10.1136/heart.88.suppl_4.ivl

47 Simonson J.S., Schiller N.B. Sono spirometry: A new method for noninvasive estimation of mean right atrial pressure based on two-dimensional echographic measurements of the inferior vena cava during measured inspiration. J Am Coll Cardiol 1988; 11: 557 - 564.

48 Simpson J., Lopez L., Acar P., Friedberg M.K., Khoo N.S., Ko H.H., et al. Three-dimensional Echocardiography in Congenital Heart Disease: An Expert Consensus Document from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 2017 Jan 1; 30: 1 - 27.

49 Bharucha T., Roman K.S., Anderson R.H., Vettukattil J.J. Impact of Multiplanar Review of Three-Dimensional Echocardiographic Data on Management of Congenital Heart Disease. Ann Thorac Surg 2008 Sep; 86: 875 - 881.

50 Ozturk E, Cansaran Tanidir I, Ayyildiz P, Gokalp S, Candas Kafali H, Sahin M, et al. The role of intraoperative epicardial echocardiography in pediatric cardiac surgery. Echocardiography 2018 Jul 1; 35: 999 - 1004.

51 Choi J., Heo R., Hong G.R., Chang H.J., Sung J.M., Shin S.H., et al. Differential effect of 3-dimensional color doppler echocardiography for the quantifcation of mitral regurgitation according to the severity and characteristics. Circ Cardiovasc Imaging 2014; 7: 535 - 544.

52 Jungwirth B., Mackensen G.B. Real-time 3-dimensional echocardiography in the operating room. Semin Cardiothorac Vase Anesth 2008 Dec; 12: 248 - 264.

53 Awasthy N., Girotra S., Dutta N., Azad S., Radhakrishnan S., Iyer K. A systematic approach to epicardial echocardiography in pediatric cardiac surgery: An important but underutilized intraoperative tool. Ann Pediatr Cardiol 2021 Apr 1; 14: 192 - 200.

54 Ozttirk E., Tanidir I., Kamali H., Ayyildiz P., Topel C., Selen Onan I., et al. Comparison of echocardiography and 320-row multidetector computed tomography for the diagnosis of congenital heart disease in children. Rev Port Cardiol 2021 Aug; 40: 583 - 590.

55 Erratum: 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) (European Respiratory Journal (2015) 46 (903 - 975)). Eur Respir J 2015 Dec 1; 46: 1855 - 1856.

56 Guazzi M., Labate V., Vitelli A. Letter by Guazzi et al regarding article, comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation 2012 Aug 21; 126. DOI: 10.1161/CIRCULATIONAHA. 111.089698

57 Применение теста 6-минутной ходьбы для оценки физической выносливости детей и подростков, лечившихся от онкологических заболеваний. Современные проблемы науки и образования (электронный научный журнал) [cited 2021 Sep 3]; Available from: https://science-education.m/ru/article/view?id=28343

58 Ulrich S., Hildenbrand F.F., Treder U., Fischler M., Keusch S., Speich R., et al. Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland. BMC Pulm Med 2013 Aug 5; 13. DOI: 10.1186/1471-2466-13-49

59 Oliveira A.C., Rodrigues C.C., Rolim D.S., Souza A.A., Nascimento O.A., Jardim J.R., et al. Six-minute walk test in healthy children: is the leg length important? Pediatr Pulmonol 2013 Sep; 48: 921 - 926.

60 Hassan J., Van Der Net J., Helders P.J.M., Prakken B.J., Takken T. Six-minute walk test in children with chronic conditions. Br J Sports Med 2010 Mar; 44: 270 - 274.

61 Cacau L de A.P., de Santana-Filho V.J., Maynard L.G., Neto M.G., Fernandes M., Carvalho V.O. Reference values for the six-minute walk test in healthy children and adolescents: A systematic review. Brazilian J Cardiovasc Surg2016 Sep 1; 31: 381 - 388.

62 Hassan J., van der Net J., Helders P.J., Prakken B.J., Takken T. Six-minute walk test in children with chronic conditions. Br J Sports Med 2010 Mar; 44: 270 - 274.

63 Enright PL The six-minute walk test. Respir Care 2003 Aug; 48: 783 - 785.

64 ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002 Jul 1; 166: 111 - 117.

65 Бубнова МГ, Персиянова-Дуброва АЛ Применение теста с шестиминутной ходьбой в кардиореабилитации. Кардиоваскулярная терапия и профилактика 2020 Jul 13; 19: 2561.

66 Grosse-Wortmann L., Kreitz S., Grabitz R., Vazquez-Jimenez J., Messmer B., von Bemuth G., et al. Prevalence of and risk factors for perioperative arrhythmias in neonates and children after cardiopulmonary bypass: continuous holter monitoring before and for three days after surgery. J Cardiothorac Surg2010 Oct 18;5. DOI: 10.1186/1749-8090-5-85

67 Sawant A., Bhardwaj A., Srivatsa S., Sridhara S., Prakash M., Kanwar N., et al. Prognostic value of frontal QRS-T angle in predicting survival after primary percutaneous coronary revascularization/coronary artery bypass grafting for ST-elevation myocardial infarction. Indian Heart J 2019 Nov 1; 71: 481 - 487.

68 Houck C., Ramdjan T., Yaksh A., Teuwen C., banters E., Bogers A., et al. Intraoperative arrhythmias in children with congenital heart disease: transient, innocent events? Europace 2018 Jul I; 20: e115 - e123.

69 Clark B., Berger J., Berul C., Jonas R., Kaltman J., Lapsa J., et al. Risk Factors for Development of Ectopic Atrial Tachycardia in Post-operative Congenital Heart Disease. Pediatr Cardiol 2018 Mar 1; 39: 459 - 465.

70 Ayyildiz P., Kasar T., Ozturk E., Ozyilmaz I., Tanidir I, Guzeltas A., et al. Evaluation of Permanent or Transient Complete Heart Block after Open Heart Surgery for Congenital Heart Disease. Pacing Clin Electrophysiol 2016 Feb 1; 39: 160 - 165.

71 Mildh L., Hiippala A., Rautiainen P., Pettila V., Sairanen H., Happonen J. Junctional ectopic tachycardia after surgery for congenital heart disease: incidence, risk factors and outcome. Eur J Cardiothorac Surg 2011 Jan; 39: 75 - 80.

72 Ahmed H., VanderPluym C Medical management of pediatric heart failure. Cardiovasc Diagn Ther 2021 Feb 1; 11. DOI: 10.21037/CDT-20-358

73 Masarone D., Valente F., Rubino M., Vastarella R., Gravino R., Rea A., et al. Pediatric Heart Failure: A Practical Guide to Diagnosis and Management. Pediatr Neonatol 2017 Aug 1; 58: 303 - 312.

74 Das B.B., Moskowitz W.B., Butler J. Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials. Children 2021 Apr 22; 8: 322.

75 Shaddy R., George A., Jaecklin T., Lochlainn E., Thakur L., Agrawal R., et al. Systematic Literature Review on the Incidence and Prevalence of Heart Failure in Children and Adolescents. Pediatr Cardiol 2018 Mar 1; 39: 415 - 436.

76 Torok R., Li J., Kannankeril P., Atz A., Bishai R., Bolotin E., et al. Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank. J Am Heart Assoc 2018 Feb 1; 7. DOI: 10.1161/JAHA.117.007283

77 Kantor P., Lougheed J., Dancea A., McGillion M., Barbosa N., Chan C., et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can J Cardiol 2013 Dec; 29: 1535 - 1552.

78 Gong B., Li Z., Yat Wong P.C. Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis. J Cardiothorac Vase Anesth 2015 Dec 1; 29: 1415 - 1425.

79 Burkhardt B.E.U., Rticker G., Stiller B. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease. Cochrane Database Syst Rev 2015 Mar 25; 2015.

80 Thorlacius E., Vistnes M., Ojala T., Keski-Nisula J., Molin M., Romlin B., et al. Levosimendan Versus Milrinone and Release of Myocardial Biomarkers After Pediatric Cardiac Surgery: Post Hoc Analysis of Clinical Trial Data. Pediatr Crit Care Med 2021; 22: E402 - E409.

81 Thorlacius E.M., Suominen P.K., Wahlander H., Keski-Nisula J., Vistnes M., Ricksten S.E., et al. The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial. Pediatr Crit Care Med 2019 Oct 1; 20: 947 - 956.

82 Lechner E., Hofer A., Leitner-Peneder G., Freynschlag R., Mair R., Weinzettel R., et al. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: A pilot study. Pediatr Crit Care Med 2012 Sep; 13: 542 - 548.

83 Raja S.G., Rayen B.S. Levosimendan in cardiac surgery: Current best available evidence. Ann Thorac Surg 2006 Apr; 81: 1536 - 1546.

84 Hussey A., Weintraub R. Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure. Paediatr Drugs 2016 Apr 1; 18: 89 - 99.

85 Thorlacius E.M., Wahlander H., Ojala T., Ylanen K., Keski-Nisula J., Synnergren M., et al. Levosimendan Versus Milrinone for Inotropic Support in Pediatric Cardiac Surgery: Results From a Randomized Trial. J Cardiothorac Vase Anesth 2020 Aug 1; 34: 2072 - 2080.

86 Long Y., Cui D., Kuang X., Hu S., Hu Y., Liu Z. Effect of Levosimendan on Ventricular Systolic and Diastolic Functions in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol 2021 Jun 1; 77: 805 - 813.

87 Jothinath K., Balakrishnan S., Raju V., Menon S., Osborn J. Clinical efficacy of levosimendan vs milrinone in preventing low cardiac output syndrome following pediatric cardiac surgery. Ann Card Anaesth 2021 Apr 1; 24: 217 - 223.

88 Das B. Current State of Pediatric Heart Failure. Children 2018 Jun 28; 5: 88.

89 Bajcetic M. Uzelac T., Jovanovic I. Heart Failure Pharmacotherapy: Differences Between Adult and Paediatric Patients. Curr Med Chem 2014 Aug 13; 21: 3108 - 3120.

90 Colan S. Review of the International Society for Heart and Lung Transplantation Practice guidelines for management of heart failure in children. Cardiol Young 2015 Sep 17; 25 Suppl 2: 154 - 159.

91 Del Castillo S., Shaddy R., Kantor P. Update on pediatric heart failure. Curr Opin Pediatr 2019 Oct 1; 31: 598 - 603.

92 O'Connor M., Rosenthal D., Shaddy R. Outpatient management of pediatric heart failure. Heart Fail Clin 2010 Oct; 6: 515 - 529.

93 Bohm M., Young R., Jhund P.S., Solomon S.D., Gong J., Lefkowitz M.P., et al. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/ valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: Results from PAR ADIGM-HF. Eur Heart J 2017 Apr 14; 38: 1132 - 1143.

94 Ahmed H., VanderPluym C. Medical management of pediatric heart failure. Cardiovasc Diagn Ther 2021 Feb 1; 11. DOI: 10.21037/CDT-20-358

95 Borer J.S., Shanna A. Drug therapy for heart valve diseases. Circulation 2015 Sep 15; 132: 1038 - 1045.

96 Sasayama S., Ohyagi A., Lee J.D., Nonogi H., Sakurai T., Wakabayashi A., et al. Effect of the Vasodilator Therapy in Regurgitant Valvular Disease. Jpn Circ J 1982; 46: 433 - 441.

97 Wang A., Graybum P., Foster J.A., McCulloch M.L., Badhwar V., Gammie J.S., et al. Practice gaps in the care of mitral valve regurgitation: Insights from the American College of Cardiology mitral regurgitation gap analysis and advisory panel. Am Heart J 2016 Feb 1; 172: 70 - 79.

98 Harris K.M., Pastorius C.A., Duval S., Harwood E., Henry T.D., Carabello B.A., et al. Practice Variation Among Cardiovascular Physicians in Management of Patients With Mitral Regurgitation. Am J Cardiol 2009 Jan 15; 103: 255 - 261.

99 Bach D.S., Awais M., Gurm H.S., Kohnstamm S. Failure of Guideline Adherence for Intervention in Patients With Severe Mitral Regurgitation. J Am Coll Cardiol 2009 Aug 25; 54: 860 - 865.

100 Lechner E., Hofer A., Leitner-Peneder G., Freynschlag R., Mair R., Weinzettel R., et al. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery. Pediatr Crit Care Med 2012 Sep; 13: 542 - 548.

101 Ricci Z., Garisto C., Favia I., Vitale V., Di Chiara F., Cogo P.E. Fevosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Intensive Care Med 2012 Jul 18; 38: 1198-204.

102 Boegli Y.O., Gioanni S., van Steenberghe M., Pouard P. Fevosimendan in a neonate with severe coarctation of aorta and low cardiac output syndrome. Ann Card Anaesth 2013; 16: 212-4.

103 Jentzer J., Temus B., Eleid V., Rihal C. Structural Heart Disease Emergencies. J Intensive Care Med 2021 Sep 1; 36: 975 - 988.

104 Wang H., Fuo Q., Fi Y., Zhang F., Wu X., Yan F. Effect of Prophylactic Fevosimendan on All-Cause Mortality in Pediatric Patients Undergoing Cardiac Surgery-An Updated Systematic Review and Meta-Analysis. Front Pediatr 2020 Aug 14; 8. DOI: 10.3389/FPED.2020.00456

105 Wang A., Cui C., Fan Y., Zi J., Zhang J., Wang G., et al. Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial. Crit Care 2019 Dec 30; 23. DOI: 10.1186/S13054-019-2704-2

106 Hummel J., Riicker G., Stiller B. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. Cochrane database Syst Rev 2017 Mar 6; 3. DOI: 10.1002/14651858.CD011312.PUB2

107 Abril-Molina A., Gomez-Fuque J., Perin F., Esteban-Molina M., Ferreiro-Marzal A., Femandez-Guerrero C., et al. Effect of Preoperative Infusion of Fevosimendan on Biomarkers of Myocardial Injury and Haemodynamics After Paediatric Cardiac Surgery: A Randomised Controlled Trial. Drugs R D 2021 Mar 1; 21: 79 - 89.

108 Malaspinas I, Petak F, Chok F, Perrin A, Martin AF, Beghetti M, et al. Surgical Repair of Mitral Valve Disease in Children: Perioperative Changes in Respiratory Function. J Cardiothorac Vase Anesth 2016 Oct 1; 30: 1286 - 1295.

109 Diez C.C., Khalil F., Schwender H., Dalinghaus M., Jovanovic I., Makowski N., et al. Pharmacotherapeutic management of paediatric heart failure and ACE-I use patterns: a European survey. BMJ Paediatr open 2019 Jan 1; 3. DOI: 10.1136/BMJPO-2018-000365

110 Momma K. ACE inhibitors in pediatric patients with heart failure. Paediatr Drugs 2006; 8: 55 - 69.

111 Stanford A.H., Reyes M., Rios D.R., Giesinger R.E., Jetton J.G., Bischoff A.R., et al. Safety, Feasibility, and Impact of Enalapril on Cardiorespiratory Physiology and Health in Preterm Infants with Systemic Hypertension and Left Ventricular Diastolic Dysfunction. J Clin Med 2021 Oct 1; 10. DOI: 10.3390/JCM10194519

112 Mathur K., Hsu D.T., Lamour J.M., Aydin S.I. Safety of Enalapril in Infants: Data from the Pediatric Heart Network Infant Single Ventricle Trial. J Pediatr 2020 Dec 1; 227: 218 - 223.

113 Hsu D.T., Mital S., Ravishankar C., Margossian R., Li J.S., Sleeper L.A., et al. Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle. Am Heart J 2009 Jan; 157: 37 - 45.

114 Kirk R., Dipchand A., Rosenthal D., Addonizio L., Burch M., Chrisant M., et al. The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary. [Corrected], J Heart Lung Transplant 2014; 33: 888 - 909.

115 Butts R., Atz A., BaezHemandez N., Sutcliffe D., Reisch J., Mahony L. Carvedilol Does Not Improve Exercise Performance in Fontan Patients: Results of a Crossover Trial. Pediatr Cardiol 2021 Apr 1; 42: 934 - 941.

116 Alabed S., Sabouni A., Al Dakhoul S., Bdaiwi Y., Frobel-Mercier A. Beta-blockers for congestive heart failure in children. Cochrane database Syst Rev 2016 Jan 28; 2016. DOI: 10.1002/14651858.CD007037.PUB3

117 Albers S., Meibohm B., Mir T., Laer S. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. Br J Clin Pharmacol 2008 Apr; 65: 511 - 522.

118 Varadarajan P., Joshi N., Appel D., Duvvuri L., Pai R.G. Effect of Beta-Blocker Therapy on Survival in Patients With Severe Mitral Regurgitation and Normal Left Ventricular Ejection Fraction. Am J Cardiol 2008 Sep 1; 102: 611 - 615.

119 Ahmed M.I., Aban I., Lloyd S.G., Gupta H., Howard G., Inusah S., et al. A randomized controlled phase lib trial of Beta 1-receptor blockade for chronic degenerative mitral regurgitation. J Am Coll Cardiol 2012 Aug 28;60:833-838.

120 Alabed S., Sabouni A., Al Dakhoul S., Bdaiwi Y. Beta-blockers for congestive heart failure in children. Cochrane database Syst Rev 2020 Jul 23; 7. DOI: 10.1002/14651858.CD007037.PUB4

121 Shaddy R., Tani L., Gidding S., Pahl E., Orsmond G., Gilbert E., et al. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transplant 1999 Mar; 18: 269 - 274.

122 Shaddy R., Boucek M., Hsu D., Boucek R., Canter C., Mahony L., et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007 Sep 12; 298: 1171 - 1179.

123 Shaddy R., Boucek M., Hsu D., Boucek R., Canter C., Mahony L., et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007 Sep 12; 298: 1171 - 1179.

124 Azeka E., Franchini Ramires J., Valler C., Alcides Bocchi E. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. J Am Coll Cardiol 2002 Dec 4; 40: 2034 - 2038.

125 Schranz D., Voelkel N. "Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr 2016 Apr 1; 175: 445 - 455.

126 Miyamoto S., Stauffer B., Nakano S., Sobus R., Nunley K., Nelson P., et al. Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy. Eur Heart J 2014 Jan 1; 35: 33 - 41.

127 Miyamoto S., Stauffer B., Polk J., Medway A., Friedrich M., Haubold K., et al. Gene expression and [3-adrenergic signaling are altered in hypoplastic left heart syndrome. J Heart Lung Transplant 2014; 33: 785 - 793.

128 Al-Alaiyan S., Arabia S., Al-Ghamdi N., Phann B. Neonatal Dosage and Practical Guidelines Handbook 2 nd Edition. Al-Alaiyan Riyadh, 2014, King Fahd National library Ministry of Health Kingdom of Saudi Arabia.

129 Abdel Jalil M., Abdullah N., Alsous M., Saleh M., Abu-Hammour K. A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population. Br J Clin Pharmacol 2020 Jul 1; 86: 1267 - 1280.

130 Ratnapalan S., Griffiths K., Costei A.M., Benson L., Koren G. Digoxin-carvedilol interactions in children. J Pediatr 2003 May 1; 142: 572 - 574.

131 Moser-Bracher A., Balrner C., Cavigelli A., Satir A., Caduff Good A., Klauwer D. Digoxin Toxicity in a Neonate Caused by the Interaction with Carvedilol. Klin Padiatr 2017 Mar 1; 229: 90 - 92.

132 Miller J., Thomas A., Johnson P. Use of continuous-infusion loop diuretics in critically ill children. Pharmacotherapy 2014; 34: 858 - 867.

133 Ricci Z., Haiberger R., Pezzella C., Garisto C., Favia I., Cogo P. Furosemide versus ethacrynic acid in pediatric patients undergoing cardiac surgery: A randomized controlled trial. Crit Care 2015 Jan 7; 19. DOI: 10.1186/S13054-014-0724-5

134 Haiberger R., Favia I., Romagnoli S., Cogo P., Ricci Z. Clinical Factors Associated with Dose of Loop Diuretics After Pediatric Cardiac Surgery: Post Hoc Analysis. Pediatr Cardiol 2016 Jun 1; 37: 913 - 918.

135 Senzaki H., Kamiyama M., Masutani S., Ishido H., Taketazu M., Kobayashi T., et al. Efficacy and safety of torasemide in children with heart failure. Arch Dis Child 2008 Sep; 93: 768 - 771.

136 Van Der Vorst M.M.J., Kist J.E., Van Der Heijden A.J., Burggraaf J. Diuretics in pediatrics: current knowledge and future prospects. Paediatr Drugs 2006; 8: 245 - 264.

137 Senzaki H., Kamiyama M., Masutani S., Ishido H., Taketazu M., Kobayashi T., et al. Efficacy and safety of torasemide in children with heart failure. Arch Dis Child 2008 Sep; 93: 768 - 771.

138 Wilson W., Taubert K.A., Gewitz M., Lockhart P.B., Baddour L.M., Levison M., et al. Prevention of infective endocarditis: Guidelines from the American Heart Association. J Am Dent Assoc 2008; 139. DOI: 10.14219/jada. archive.2008.0346

139 Baumgartner H., lung B., Otto C.M. Timing of intervention in asymptomatic patients with valvular heart disease. Eur Heart J 2020 Dec 1;41:4349-4356.

140 Shah M., Jorde U.P. Percutaneous Mitral Valve Interventions (Repair): Current Indications and Future Perspectives. Front Cardiovasc Med 2019 [cited 2021 Aug 20]; 6: 88.

141 Momingstar J., Nieman A., Wang C., Beck T., Harvey A., Norris R. Mitral Valve Prolapse and Its Motley Crew-Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition. J Am Heart Assoc 2021 Jul6;10. DOI: 10.1161/JAHA. 121.020919

142 Barbanti M., Costa G. Highlights from the 2020 ACC/AHA guidelines on valvular heart disease. Euro Intervention 2021; 16: 1303 - 1305.

143 Mohananey D., Aljadah M., Smith A.A.H., Haines J.F., Patel S., Villablanca P., et al. The 2020 ACC/AHA Guidelines for Management of Patients With Valvular Heart Disease: Highlights and Perioperative Implications. J Cardiothorac Vase Anesth 2021; DOI: 10.1053/J.JVCA.2021.04.013

144 Alame A.J., Karatasakis A., Karacsonyi J., Danek B.A., Sorajja P., Gossl M., et al. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology Guidelines for the Management of Patients with Valvular Heart Disease. J Invasive Cardiol 2017 Sep 1; 29: 320 - 326.

145 Lamm G. New strategies in the management of valvular heart disease: A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease. Wien Klin Wochenschr 2021; 133. DOI: 10.1007/S00508-021-01879-Y

146 Wada N., Takahashi Y., Ando M., Park I.S., Kikuchi T. Mitral valve replacement in children under 3 years of age. Japanese J Thorac Cardiovasc Surg 2005; 53: 545 - 550.

147 Yuan H., Wu Z., Lu T., Tang Y., Chen J., Yang Y., et al. Long-term outcomes of mitral valve replacement in patients weighing less than 10 kg. J Cardiothorac Surg 2021 Dec 1; 16. DOI: 10.1186/sl 3019-021-01443-9

148 Brown J.W., Fiore A.C., Ruzmetov M., Eltayeb O., Rodefeld M.D., Turrentine M.W. Evolution of mitral valve replacement in children: a 40-year experience. Ann Thorac Surg 2012 Feb; 93: 626-33; discussion 633.

149 Masuda M., Kado H., Tatewaki H., Shiokawa Y., Yasui H. Late results after mitral valve replacement with bileaflet mechanical prosthesis in children: Evaluation of prosthesis-patient mismatch. Ann Thorac Surg 2004; 77: 913 - 917.

150 Brancaccio G., Trezzi M., Chinali M., Vignaroli W., D'Anna C., Iodice F., et al. Predictors of survival in paediatric mitral valve replacement. Eur J Cardio-Thoracic Surg 2021 Feb 14; DOI: 10.1093/ejcts/ezab078

151 Ibezim C., Sarvestani A.L., Knight J.H., Qayum O., Alshami N., Turk E., et al. Outcomes of Mechanical Mitral Valve Replacement in Children. Ann Thorac Surg 2019 Jan 1; 107: 143 - 150.

152 Okamoto T., Nakano T., Goda M., Oda S., Kado H. Outcomes of mitral valve replacement with bileaflet mechanical prosthetic valve in children. Gen Thorac Cardiovasc Surg 2020 Jun 1; 68: 571 - 577.

153 Choi P.S., Sleeper L.A., Lu M., Upchurch P., Baird C., Emani S.M. Revisiting prosthesis choice in mitral valve replacement in children: Durable alternatives to traditional bioprostheses; in: Journal of Thoracic and Cardiovascular Surgery. Mosby Inc., 2021, pp 213 - 225.e3.

154 Alghamdi A.A., Yanagawa B., Singh S.K., Horton A., Al-Radi OO, Caldarone CA Balancing stenosis and regurgitation during mitral valve surgery in pediatric patients. Ann Thorac Surg 2011 Aug; 92: 680 - 4.

155 Oppido G., Davies B., McMullan D.M., Cochrane A.D., Cheung MMH, d'Udekem Y, et al. Surgical treatment of congenital mitral valve disease: Midterm results of a repair-oriented policy. J Thorac Cardiovasc Surg 2008; 135. DOI: 10.1016/j.jtcvs.2007.09.071

156 Geofffion T.R., Pirolli T.J., Pruszynski J., Dyer A.K., Davies R.R., Forbess J.M., et al. Mitral Valve Surgery in the First Year of Life. Pediatr Cardiol 2020 Feb 1; 41: 334 - 340.

157 Sawan E.B., Brink J., Soquet J., Liava'a M., Brizard C.P., Konstantinov I.E., et al. The ordeal of left atrioventricular valve replacement in children under 1 year of age; in: Interactive Cardiovascular and Thoracic Surgery. Oxford University Press, 2017, pp 317 - 322.

158 Selamet Tierney E.S., Pigula F.A., Berul C.l., Lock J.E., del Nido P.J., McElhinney D.B. Mitral valve replacement in infants and children 5 years of age or younger: Evolution in practice and outcome over three decades with a focus on supra-annular prosthesis implantation. J Thorac Cardiovasc Surg 2008; 136. DOI: 10.1016/j.jtcvs.2007.12.076

159 Mayr B., Vitanova K., Burri M., Lang N., Goppel G., Voss B., et al. Mitral Valve Repair in Children Below Age 10 Years: Trouble or Success?; in: Annals of Thoracic Surgery. Elsevier Inc., 2020, pp 2082 - 2087.

160 Elsisy M.F., Dearani J.A., Ashikhmina E., Krishnan P., Anderson J.H., Taggart N.W., et al. What Factors Should Be Considered to Improve Outcome of Mechanical Mitral Valve Replacement in Children? World J Pediatr Congenit Hear Surg 2021 May; 12: 367 - 374.

161 Beierlein W., Becker V., Yates R., Tsang V., Elliott M., de Leval M., et al. Long-term follow-up after mitral valve replacement in childhood: poor event-free survival in the young child. Eur J Cardio-thoracic Surg 2007 May; 31: 861 - 866.

162 Caldarone CA, Raghuveer G, Hills CB, Atkins DL, Bums TL, Behrendt DM, et al. Long-Term Survival After Mitral Valve Replacement in Children Aged < 5 Years. Circulation 2001 Sep 18; 104: 1-143-1-147.

163 Ackennann K., Balling G., Eicken A., Gtinther T., Schreiber C., Hess J. Replacement of the systemic atrioventricular valve with a mechanical prosthesis in children aged less than 6 years: Late clinical results of survival and subsequent replacement. J Thorac Cardiovasc Surg 2007 Sep; 134: 750 - 756.

164 Jamart L., Duchanne A., Garceau P., Basmadjian A., Dorval J., Bouchard D., et al. Optimizing Timing of Valve Intervention in Patients With Asymptomatic Severe Valvular Heart Disease. Can J Cardiol 2021 Jul 1; 37: 1041 - 1053.

165 Baird C., Myers P., Marx G., Del Nido P. Mitral valve operations at a high-volume pediatric heart center: Evolving techniques and improved survival with mitral valve repair versus replacement; in: Annals of Pediatric Cardiology. Ann Pediatr Cardiol, 2012, pp 13 - 20.

166 Stellin G., Padalino M.A., Vida V.L., Boccuzzo G., Orr E., Biftanti R., et al. Surgical repair of congenital mitral valve malformations in infancy and childhood: A single-center 36-year experience. J Thorac Cardiovasc Surg 2010 Dec; 140: 1238 - 1244.

167 Brancaccio G., Chinali M., Trezzi M., D'Anna C., Esposito C., Rinelli G., et al. Outcome for Conservative Surgery for the Correction of Severe Mitral Valve Regurgitation in Children: A Single-Center Experience. Pediatr Cardiol 2019 Dec 1; 40: 1663 - 1669.

168 Geoffrion T.R., Pirolli T.J., Pmszynski J., Dyer A.K., Davies R.R., Forbess J.M., et al. Mitral Valve Surgery in the First Year of Life. Pediatr Cardiol 2020 Feb 1; 41: 334 - 340.

169 Myers P.O., Baird C.W., Del Nido P.J., Pigula F.A., Lang N., Marx G.R., et al. Neonatal Mitral Valve Repair in Biventricular Repair, Single Ventricle Palliation, and Secondary Left Ventricular Recruitment: Indications, Techniques, and Mid-Term Outcomes. Front Surg 2015 Nov 10; 2: 59.

170 Jiang Z., Mei J., Ding F., Bao C., Zhu J., Tang M., et al. The early and mid-term results of mitral valve repair for mitral regurgitation in children. Surg Today 2014 Oct 11; 44: 2086 - 2091.

171 Hoashi T., Bove E.L., Devaney E.J., Hirsch J.C., Ohye R.G. Mitral valve repair for congenital mitral valve stenosis in the pediatric population. Ann Thorac Surg 2010 Jul; 90: 36 - 41.

172 Delrno Walter E.M., Hetzer R. Repair for Congenital Mitral Valve Stenosis. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2018 Mar 1; 21: 46 - 57.

173 Wood A.E., Healy D.G., Nolke L., Duff D., Oslizlok P., Walsh K. Mitral valve reconstruction in a pediatric population: Late clinical results and predictors of long-term outcome. J Thorac Cardiovasc Surg 2005 Jul; 130: 66 - 73.

174 Beierlein W., Becker V., Yates R., Tsang V., Elliott M., de Leval M., et al. Long-term follow-up after mitral valve replacement in childhood: poor event-free survival in the young child. Eur J Cardio-thoracic Surg 2007 May; 31: 861 - 866.

175 Shi Y., Xu H., Yan J., Wang Q., Li S., Yi T., et al. The Mid-term Results of Mitral Valve Repair for Isolated Mitral Regurgitation in Infancy and Childhood. Pediatr Cardiol 2017 Dec 1; 38: 1592 - 1597.

176 Baghaei R., Tabib A., Jalili F., Totonchi Z., Mahdavi M., Ghadrdoost B. Early and Mid-Term Outcome of Pediatric Congenital Mitral Valve Surgery. Res Cardiovasc Med 2015 Aug; 4: e28724.

177 Kalangos A., Christenson J.T., Beghetti M., Cikirikcioglu M., Kamentsidis D., Aggoun Y. Mitral Valve Repair for Rheumatic Valve Disease in Children: Midterm Results and Impact of the Use of a Biodegradable Mitral Ring. Ann Thorac Surg 2008 Jul; 86: 161 - 169.

178 del Nido P.J., Baird C. Congenital Mitral Valve Stenosis: Anatomic Variants and Surgical Reconstruction. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2012; 15: 69 - 74.

179 Fuller S., Spray T.L. How I Manage Mitral Stenosis in the Neonate and Infant. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009; 12: 87 - 93.

180 Lamberti J.J., Kriett J.M. Mitral/Systemic Atrioventricular Valve Repair in Congenital Heart Disease. Pediatr Card Surg Annu 2007; 10: 94 - 100.

181 Baird C.W., Marx G.R., Borisuk M., Emani S., del Nido PJ Review of Congenital Mitral Valve Stenosis: Analysis, Repair Techniques and Outcomes. Cardiovasc Eng Technol 2015 Jun 1; 6: 167 - 173.

182 Chauvaud S. Congenital mitral valve surgery: Techniques and results. Curr Opin Cardiol 2006 Mar; 21: 95 - 99.

183 Cikirikcioglu M., Pektok E., Myers P.O., Christenson J.T., Kalangos A. Pediatric mitral valve repair with the novel annuloplasty ring: Kalangos-Bioring(R). Asian Cardiovasc Thorac Ann 2008; 16: 515 - 516.

184 Honjo O., Ishino K., Kawada M., Akagi T., Sano S. Midterm outcome of mitral valve repair for congenital mitral regurgitation in infants and children; in: Interactive Cardiovascular and Thoracic Surgery. Interact Cardiovasc Thorac Surg, 2006, pp 589 - 593.

185 Nishimura R.A., Otto C.M., Bonow R.O., Carabello B.A., Erwin J.P., Fleisher L.A., et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017 Jul ll; 70: 252 - 289.

186 Feltes T.F., Bacha E., Beekman R.H., Cheatham J.P., Feinstein J.A., Gomes A.S., et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: A scientific statement from the American Heart Association. Circulation 2011 Jun 7; 123: 2607 - 2652.

187 Рыбка М.М., Хинчагов Д.Я., Мумладзе К.В. Протоколы анестезиологического обеспечения кардиохирургических операций, выполняемых у новорожденных и детей. Методические рекомендации. НЦССХим А.Н. Бакулева Москва, 2014.

188 Park M., Salamat M. Park's Pediatric Cardiology for Practitioners - 7th Edition. Elsevier 2020, [cited 2021 Jun 1]. Available from: https://www.elsevier.com/books/parks-pediatric-cardiology-for-practitioners/park/978-0-323-68107-0

189 Подзолков В.П., Кассирский Е.И. Реабилитация больных после хирургического лечения врожденных пороков сердца. НССХХ им А.Н. Бакулева Москва, 2015, [cited 2021 Jun 1]. Available from: https://science.bakulev.m/publish_/book/detail.php?ID=8953

190 Dos L., Rueda Soriano J., Avila P., Escribano P., Garrido-Lestache Rodriguez-Monte M.E., Gonzalez A.E., et al. Coimnents on the 2020 ESC guidelines for the management of adult congenital heart disease. Rev Espanola Cardiol (English Ed 2021 May); 74: 371 - 377.

191 Crawford M.H., Souchek J., Oprian C.A., Miller D.C., Rahimtoola S., Giacomini J.C., et al. Determinants of survival and left ventricular performance after mitral valve replacement. Circulation 1990; 81: 1173 - 1181.

192 Inciardi R.M., Rossi A., Benfari G., Cicoira M. Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis. Curr Heart Fail Rep 2018 Apr 1; 15: 106 - 115.

193 Allen N., O'sullivan K., Jones J.M. The most influential papers in mitral valve surgery; a bibliometric analysis. J Cardiothorac Surg 2020 Jul 20; 15. DOI: 10.1186/sl3019-020-01214-y

194 Phillips H.R., Levine F.H., Carter J.E., Boucher C.A., Osbakken M.D., Okada R.D., et al. Mitral valve replacement for isolated mitral regurgitation: Analysis of clinical course and late postoperative left ventricular ejection fraction. Am J Cardiol 1981; 48: 647 - 654.

195 Gomez-Doblas J.J., Schor J., Vignola P., Weinberg D., Traad E., Carrillio R., et al. Left ventricular geometry and operative mortality in patients undergoing mitral valve replacement. Clin Cardiol 2001; 24: 717 - 722.

196 Leung D.Y., Griffin B.P., Stewart W.J., Cosgrove D.M., Thomas J.D., Marwick TH Left ventricular function after valve repair for chronic mitral regurgitation: Predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol 1996 Nov 1; 28: 1198 - 1205.

197 Wisenbaugh T., Skudicky D., Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 1994; 89: 191 - 197.

198 Nitsche C., Koschutnik M., Kammerlander A., Hengstenberg C., Mascherbauer J. Gender-specific differences in valvular heart disease. Wien Klin Wochenschr 2020 Feb 1; 132: 61 - 68.

199 Chowdhury U.K., Kumar A.S., Airan B., Mittal D., Subramaniam K.G., Prakash R., et al. Mitral valve replacement with and without chordal preservation in a rheumatic population: Serial echocardiographic assessment of left ventricular size and function. Ann Thorac Surg 2005 Jun; 79: 1926 - 1933.

200 Cannegieter S.C., Rosendaal F.R., Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635 - 641.

201 Trzeciak P., Zembala M., Polonski L. Major hemorrhagic and thromboembolic complications in patients with mechanical heart valves receiving oral anticoagulant therapy. Heart Surg Forum 2010 Apr; 13. DOI: 10.1532/HSF98.20091097

202 Ino N., Masutani S., Tanikawa S., Iwamoto Y., Saiki H., Ishido H., et al. Effects of home prothrombin international ratio (PT-INR) management in children with mechanical prosthetic valves - Importance of individual correlations between laboratory and CoaguChek device PT-INRs. J Cardiol 2018 Feb 1; 71: 187 - 191.

203 Jain S., Vaidyanathan B. Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature. Ann Pediatr Cardiol 2010 Jan [cited 2021 Aug 20]; 3: 31-4.

204 Jain S., Vaidyanathan B. Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature. Ann Pediatr Cardiol 2010 Jan 1; 3: 31 - 34.

205 Prevention of thrombosis and embolism in children and adolescents with mechanical valve prostheses: warfarin versus antiplatelet agents - PubMed [cited 2021 Aug 20]; Available from: https://pubmed.ncbi.nhn.nih.gov/16784079/

206 Stein P.D., Alpert J.S., Bussey H.I., Dalen J.E., Turpie AGG Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001 Jan 1; 119: 220S - 227S.

207 Mok C.K., Boey J., Wang R., Chan T.K., Cheung K.L., Lee P.K., et al. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: A prospective randomized clinical trial. Circulation 1985; 72: 1059 - 1063.

208 Bradley L.M., Midgley F.M., Watson D.C., Getson P.R., Scott L.P. Anticoagulation therapy in children with mechanical prosthetic cardiac valves. Am J Cardiol 1985 Sep 15; 56: 533 - 535.

209 Jobs A., Stiennaier T., Klotz S., Eitel I. Antiplatelet or anticoagulative strategies after surgical/interventional valve treatment. Herz 2018 Feb 1; 43: 26 - 33.

210 Harkin M., Shaddix B., Neely S., Peek L., Stephens K., Barker P., et al. Evaluation of dosing and safety outcomes of low-dose prophylactic warfarin in children after cardiothoracic surgery. Am J Health Syst Phann 2020; 77: 1018 - 1025.

211 Monagle P., Chan A., Goldenberg N., Ichord R., Joumeycake J., Nowak-Gottl U., et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e737S - e801S.

212 Whitlock R.P., Sun J.C., Fremes S.E., Rubens F.D., Teoh K.H. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012; 141: e576S - e600S.

213 Cao H., Wu T., Chen W., Fu J., Xia X., Zhang J. The effect of warfarin knowledge on anticoagulation control among patients with heart valve replacement. Int J Clin Phann 2020 Jun 1; 42: 861 - 870.

214 Galie N., Humbert M., Vachiery J.F., Gibbs S., Fang I., Torbicki A., et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016 Jan 1; 37: 67 - 119.